Clinical and demographic data.
| Group | Patients, n | Mean Age, Yrs | Female Sex, % | Disease Pattern (poly, oligo, axial, combined, %) | Arthritis Duration, Yrs | Psoriasis Duration, Yrs | MTX, % of Patients (mg/week) |
|---|---|---|---|---|---|---|---|
| All patients | 93 | 53.4 | 52.7 | 48.5, 21.5, 7.5, 22.6 | 15 | 20.8 | 25.8 (13.3) |
| Infliximab | 24 | 50.9 | 45.8 | 50, 8.3, 8.3, 33.3 | 14 | 21.6 | 20.8 (14.5) |
| Adalimumab | 48 | 53.8 | 54.2 | 45.8, 25, 8.3, 20.8 | 16.5 | 21.4 | 33.3 (13.2) |
| Etanercept | 21 | 55.4 | 57.1 | 52.4, 28.6, 4.8, 14.3 | 12.5 | 18.4 | 14.3 (11.7) |
Poly: polyarthritis; oligo: oligoarthritis; MTX: methotrexate.